ATE395935T1 - An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47 - Google Patents

An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47

Info

Publication number
ATE395935T1
ATE395935T1 AT00917907T AT00917907T ATE395935T1 AT E395935 T1 ATE395935 T1 AT E395935T1 AT 00917907 T AT00917907 T AT 00917907T AT 00917907 T AT00917907 T AT 00917907T AT E395935 T1 ATE395935 T1 AT E395935T1
Authority
AT
Austria
Prior art keywords
hsp47
colligin
localized
carcinoma cells
molecules
Prior art date
Application number
AT00917907T
Other languages
English (en)
Inventor
John Sauk
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE395935T1 publication Critical patent/ATE395935T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00917907T 1999-03-15 2000-03-15 An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47 ATE395935T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12448199P 1999-03-15 1999-03-15

Publications (1)

Publication Number Publication Date
ATE395935T1 true ATE395935T1 (de) 2008-06-15

Family

ID=22415145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00917907T ATE395935T1 (de) 1999-03-15 2000-03-15 An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47

Country Status (8)

Country Link
EP (1) EP1161262B1 (de)
JP (1) JP2002539175A (de)
AT (1) ATE395935T1 (de)
AU (1) AU3880900A (de)
CA (1) CA2367256A1 (de)
DE (1) DE60038955D1 (de)
ES (1) ES2302692T3 (de)
WO (1) WO2000054805A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1411061A1 (de) * 2002-10-16 2004-04-21 Centre National De La Recherche Scientifique (Cnrs) Poly-alpha2,8-sialylsäure mimetische Peptide und ihre Verwendungen
CA2539467C (en) 2003-09-08 2012-11-13 Frank Cuttitta Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
WO2005049852A2 (en) * 2003-11-17 2005-06-02 University Of Florida Methods and compositions for inducing apoptosis
WO2005124356A2 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein cbp2 as a marker for colorectal cancer
AU2005319578A1 (en) 2004-11-24 2006-06-29 Neopro Labs, Llc Methods and compositions for treating conditions
WO2008144675A1 (en) 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
US20160291025A1 (en) 2013-09-18 2016-10-06 Adelaide Research & Innovation Pty Ltd Autoantibody biomarkers of ovarian cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2660276B2 (ja) * 1993-06-21 1997-10-08 呉羽化学工業株式会社 癌悪性度の体外検出法
US5972622A (en) * 1996-02-08 1999-10-26 Desjardins; Louise Method of detecting apoptosis using an anti-human GP46 monoclonal anti-body

Also Published As

Publication number Publication date
JP2002539175A (ja) 2002-11-19
CA2367256A1 (en) 2000-09-21
WO2000054805A1 (en) 2000-09-21
EP1161262B1 (de) 2008-05-21
EP1161262A1 (de) 2001-12-12
AU3880900A (en) 2000-10-04
EP1161262A4 (de) 2003-05-14
DE60038955D1 (de) 2008-07-03
ES2302692T3 (es) 2008-08-01

Similar Documents

Publication Publication Date Title
ES2181006T3 (es) Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
DK1337629T3 (da) Dipeptidylpeptidaser
NO20021974D0 (no) Fargemerkede imidazokinolinforbindelser
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
DK1187632T3 (da) Behandling med anti-ErbB2-antistoffer
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
WO2001012661A3 (en) RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS
ATE395935T1 (de) An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47
ATE405834T1 (de) Bindungsoberfläche
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DE60017924D1 (de) Rekombinante, adenovirale vektoren und ihre verwendung zur behandlung von leberzirrhose
NO20006026L (no) Fremgangsmåter og blandinger for modulering av angiogenese ved bruk av tyrosin kinase SRC
BR0108187A (pt) Moléculas trade e usos relacionados com as mesmas
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
ATE528392T1 (de) Neues protein und dessen dns
DK1377667T3 (da) Fusionsproteiner til specifik behandling af cancer og autoimmunsygdomme
DE60032201D1 (de) Apoptin bindendes Protein
WO2001042461A3 (en) Apoptin-associating protein
DE60038667D1 (de) De peptide und ihre verwendung
EP1111045A3 (de) Apoptin-bindendes Protein
EP1185306A4 (de) Verwendung von viralen vektoren und geladenen molekülen für die gentherapie
WO2001053351A3 (en) Apoptin bindendes protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties